The global Natural Killer Cells Therapeutics market was valued at US$ 350 million in 2023 and is anticipated to reach US$ 1012.3 million by 2030, witnessing a CAGR of 16.4% during the forecast period 2024-2030.

Natural Killer Cells Therapeutics Market

Cell therapy, a new therapeutic approach that uses a patient's own immune cells to attack tumors, has emerged as one of the most promising breakthroughs in cancer treatment. NK cells are the body's first line of defense against infections and diseases with an innate ability to rapidly seek and destroy abnormal cells.

A significant driver in the Natural Killer Cells Therapeutics market is the growing interest in immunotherapy approaches for cancer treatment. Natural killer (NK) cell-based therapeutics have emerged as a promising strategy to harness the body's immune system to combat cancer. However, a notable challenge in this market is the need for scalability and manufacturing standardization. Ensuring that NK cell therapies can be produced reliably at scale while addressing challenges related to cell expansion, quality control, and patient-specific manufacturing poses a significant challenge. Researchers and manufacturers must invest in technology advancements, quality assurance processes, and regulatory compliance to make NK cell-based therapeutics widely accessible and consistently effective in the fight against cancer.

This report aims to provide a comprehensive presentation of the global market for Natural Killer Cells Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Natural Killer Cells Therapeutics.

Report Scope

The Natural Killer Cells Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Natural Killer Cells Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Natural Killer Cells Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Natural Killer Cells Therapeutics Market Report

Report Metric	Details
Report Name	Natural Killer Cells Therapeutics Market
Accounted market size in 2023	US$ 350 million
Forecasted market size in 2030	US$ 1012.3 million
CAGR	16.4%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	NK Cell Therapies NK Cell Directed Antibodies
Segment by Application	Cancer Gastrointestinal Diseases Immunoproliferative Disorders Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Affimed, Celgene, Fate Therapeutics, Fortress Biotech, Glycostem Therapeutics, Innate Pharma, Nantkwest, Nkarta Therapeutics, NKT Therapeutics, Ziopharm Oncology
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Natural Killer Cells Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Natural Killer Cells Therapeutics Market growing?

Ans: The Natural Killer Cells Therapeutics Market witnessing a CAGR of 16.4% during the forecast period 2024-2030.

What is the Natural Killer Cells Therapeutics Market size in 2030?

Ans: The Natural Killer Cells Therapeutics Market size in 2030 will be US$ 1012.3 million.

Who are the main players in the Natural Killer Cells Therapeutics Market report?

Ans: The main players in the Natural Killer Cells Therapeutics Market are Affimed, Celgene, Fate Therapeutics, Fortress Biotech, Glycostem Therapeutics, Innate Pharma, Nantkwest, Nkarta Therapeutics, NKT Therapeutics, Ziopharm Oncology

What are the Application segmentation covered in the Natural Killer Cells Therapeutics Market report?

Ans: The Applications covered in the Natural Killer Cells Therapeutics Market report are Cancer, Gastrointestinal Diseases, Immunoproliferative Disorders, Others

What are the Type segmentation covered in the Natural Killer Cells Therapeutics Market report?

Ans: The Types covered in the Natural Killer Cells Therapeutics Market report are NK Cell Therapies, NK Cell Directed Antibodies

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Natural Killer Cells Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 NK Cell Therapies

1.2.3 NK Cell Directed Antibodies

1.3 Market by Application

1.3.1 Global Natural Killer Cells Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Cancer

1.3.3 Gastrointestinal Diseases

1.3.4 Immunoproliferative Disorders

1.3.5 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Natural Killer Cells Therapeutics Market Perspective (2019-2030)

2.2 Natural Killer Cells Therapeutics Growth Trends by Region

2.2.1 Global Natural Killer Cells Therapeutics Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Natural Killer Cells Therapeutics Historic Market Size by Region (2019-2024)

2.2.3 Natural Killer Cells Therapeutics Forecasted Market Size by Region (2025-2030)

2.3 Natural Killer Cells Therapeutics Market Dynamics

2.3.1 Natural Killer Cells Therapeutics Industry Trends

2.3.2 Natural Killer Cells Therapeutics Market Drivers

2.3.3 Natural Killer Cells Therapeutics Market Challenges

2.3.4 Natural Killer Cells Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Natural Killer Cells Therapeutics Players by Revenue

3.1.1 Global Top Natural Killer Cells Therapeutics Players by Revenue (2019-2024)

3.1.2 Global Natural Killer Cells Therapeutics Revenue Market Share by Players (2019-2024)

3.2 Global Natural Killer Cells Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Natural Killer Cells Therapeutics Revenue

3.4 Global Natural Killer Cells Therapeutics Market Concentration Ratio

3.4.1 Global Natural Killer Cells Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Natural Killer Cells Therapeutics Revenue in 2023

3.5 Natural Killer Cells Therapeutics Key Players Head office and Area Served

3.6 Key Players Natural Killer Cells Therapeutics Product Solution and Service

3.7 Date of Enter into Natural Killer Cells Therapeutics Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Natural Killer Cells Therapeutics Breakdown Data by Type

4.1 Global Natural Killer Cells Therapeutics Historic Market Size by Type (2019-2024)

4.2 Global Natural Killer Cells Therapeutics Forecasted Market Size by Type (2025-2030)

5 Natural Killer Cells Therapeutics Breakdown Data by Application

5.1 Global Natural Killer Cells Therapeutics Historic Market Size by Application (2019-2024)

5.2 Global Natural Killer Cells Therapeutics Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Natural Killer Cells Therapeutics Market Size (2019-2030)

6.2 North America Natural Killer Cells Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Natural Killer Cells Therapeutics Market Size by Country (2019-2024)

6.4 North America Natural Killer Cells Therapeutics Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Natural Killer Cells Therapeutics Market Size (2019-2030)

7.2 Europe Natural Killer Cells Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Natural Killer Cells Therapeutics Market Size by Country (2019-2024)

7.4 Europe Natural Killer Cells Therapeutics Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Natural Killer Cells Therapeutics Market Size (2019-2030)

8.2 Asia-Pacific Natural Killer Cells Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Natural Killer Cells Therapeutics Market Size by Region (2019-2024)

8.4 Asia-Pacific Natural Killer Cells Therapeutics Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Natural Killer Cells Therapeutics Market Size (2019-2030)

9.2 Latin America Natural Killer Cells Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Natural Killer Cells Therapeutics Market Size by Country (2019-2024)

9.4 Latin America Natural Killer Cells Therapeutics Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Natural Killer Cells Therapeutics Market Size (2019-2030)

10.2 Middle East & Africa Natural Killer Cells Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Natural Killer Cells Therapeutics Market Size by Country (2019-2024)

10.4 Middle East & Africa Natural Killer Cells Therapeutics Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Affimed

11.1.1 Affimed Company Detail

11.1.2 Affimed Business Overview

11.1.3 Affimed Natural Killer Cells Therapeutics Introduction

11.1.4 Affimed Revenue in Natural Killer Cells Therapeutics Business (2019-2024)

11.1.5 Affimed Recent Development

11.2 Celgene

11.2.1 Celgene Company Detail

11.2.2 Celgene Business Overview

11.2.3 Celgene Natural Killer Cells Therapeutics Introduction

11.2.4 Celgene Revenue in Natural Killer Cells Therapeutics Business (2019-2024)

11.2.5 Celgene Recent Development

11.3 Fate Therapeutics

11.3.1 Fate Therapeutics Company Detail

11.3.2 Fate Therapeutics Business Overview

11.3.3 Fate Therapeutics Natural Killer Cells Therapeutics Introduction

11.3.4 Fate Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2019-2024)

11.3.5 Fate Therapeutics Recent Development

11.4 Fortress Biotech

11.4.1 Fortress Biotech Company Detail

11.4.2 Fortress Biotech Business Overview

11.4.3 Fortress Biotech Natural Killer Cells Therapeutics Introduction

11.4.4 Fortress Biotech Revenue in Natural Killer Cells Therapeutics Business (2019-2024)

11.4.5 Fortress Biotech Recent Development

11.5 Glycostem Therapeutics

11.5.1 Glycostem Therapeutics Company Detail

11.5.2 Glycostem Therapeutics Business Overview

11.5.3 Glycostem Therapeutics Natural Killer Cells Therapeutics Introduction

11.5.4 Glycostem Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2019-2024)

11.5.5 Glycostem Therapeutics Recent Development

11.6 Innate Pharma

11.6.1 Innate Pharma Company Detail

11.6.2 Innate Pharma Business Overview

11.6.3 Innate Pharma Natural Killer Cells Therapeutics Introduction

11.6.4 Innate Pharma Revenue in Natural Killer Cells Therapeutics Business (2019-2024)

11.6.5 Innate Pharma Recent Development

11.7 Nantkwest

11.7.1 Nantkwest Company Detail

11.7.2 Nantkwest Business Overview

11.7.3 Nantkwest Natural Killer Cells Therapeutics Introduction

11.7.4 Nantkwest Revenue in Natural Killer Cells Therapeutics Business (2019-2024)

11.7.5 Nantkwest Recent Development

11.8 Nkarta Therapeutics

11.8.1 Nkarta Therapeutics Company Detail

11.8.2 Nkarta Therapeutics Business Overview

11.8.3 Nkarta Therapeutics Natural Killer Cells Therapeutics Introduction

11.8.4 Nkarta Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2019-2024)

11.8.5 Nkarta Therapeutics Recent Development

11.9 NKT Therapeutics

11.9.1 NKT Therapeutics Company Detail

11.9.2 NKT Therapeutics Business Overview

11.9.3 NKT Therapeutics Natural Killer Cells Therapeutics Introduction

11.9.4 NKT Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2019-2024)

11.9.5 NKT Therapeutics Recent Development

11.10 Ziopharm Oncology

11.10.1 Ziopharm Oncology Company Detail

11.10.2 Ziopharm Oncology Business Overview

11.10.3 Ziopharm Oncology Natural Killer Cells Therapeutics Introduction

11.10.4 Ziopharm Oncology Revenue in Natural Killer Cells Therapeutics Business (2019-2024)

11.10.5 Ziopharm Oncology Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Affimed NV

Fate Therapeutics

Fortress Biotech

Glycostem Therapeutics

List of Tables

Table 1. Global Natural Killer Cells Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of NK Cell Therapies

Table 3. Key Players of NK Cell Directed Antibodies

Table 4. Global Natural Killer Cells Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Natural Killer Cells Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Natural Killer Cells Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Natural Killer Cells Therapeutics Market Share by Region (2019-2024)

Table 8. Global Natural Killer Cells Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Natural Killer Cells Therapeutics Market Share by Region (2025-2030)

Table 10. Natural Killer Cells Therapeutics Market Trends

Table 11. Natural Killer Cells Therapeutics Market Drivers

Table 12. Natural Killer Cells Therapeutics Market Challenges

Table 13. Natural Killer Cells Therapeutics Market Restraints

Table 14. Global Natural Killer Cells Therapeutics Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Natural Killer Cells Therapeutics Market Share by Players (2019-2024)

Table 16. Global Top Natural Killer Cells Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Natural Killer Cells Therapeutics as of 2023)

Table 17. Ranking of Global Top Natural Killer Cells Therapeutics Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by Natural Killer Cells Therapeutics Revenue (CR5 and HHI) & (2019-2024)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players Natural Killer Cells Therapeutics Product Solution and Service

Table 21. Date of Enter into Natural Killer Cells Therapeutics Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Natural Killer Cells Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Natural Killer Cells Therapeutics Revenue Market Share by Type (2019-2024)

Table 25. Global Natural Killer Cells Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Natural Killer Cells Therapeutics Revenue Market Share by Type (2025-2030)

Table 27. Global Natural Killer Cells Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Natural Killer Cells Therapeutics Revenue Market Share by Application (2019-2024)

Table 29. Global Natural Killer Cells Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Natural Killer Cells Therapeutics Revenue Market Share by Application (2025-2030)

Table 31. North America Natural Killer Cells Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America Natural Killer Cells Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America Natural Killer Cells Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe Natural Killer Cells Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe Natural Killer Cells Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe Natural Killer Cells Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific Natural Killer Cells Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific Natural Killer Cells Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific Natural Killer Cells Therapeutics Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America Natural Killer Cells Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America Natural Killer Cells Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America Natural Killer Cells Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa Natural Killer Cells Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa Natural Killer Cells Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa Natural Killer Cells Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 46. Affimed Company Detail

Table 47. Affimed Business Overview

Table 48. Affimed Natural Killer Cells Therapeutics Product

Table 49. Affimed Revenue in Natural Killer Cells Therapeutics Business (2019-2024) & (US$ Million)

Table 50. Affimed Recent Development

Table 51. Celgene Company Detail

Table 52. Celgene Business Overview

Table 53. Celgene Natural Killer Cells Therapeutics Product

Table 54. Celgene Revenue in Natural Killer Cells Therapeutics Business (2019-2024) & (US$ Million)

Table 55. Celgene Recent Development

Table 56. Fate Therapeutics Company Detail

Table 57. Fate Therapeutics Business Overview

Table 58. Fate Therapeutics Natural Killer Cells Therapeutics Product

Table 59. Fate Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2019-2024) & (US$ Million)

Table 60. Fate Therapeutics Recent Development

Table 61. Fortress Biotech Company Detail

Table 62. Fortress Biotech Business Overview

Table 63. Fortress Biotech Natural Killer Cells Therapeutics Product

Table 64. Fortress Biotech Revenue in Natural Killer Cells Therapeutics Business (2019-2024) & (US$ Million)

Table 65. Fortress Biotech Recent Development

Table 66. Glycostem Therapeutics Company Detail

Table 67. Glycostem Therapeutics Business Overview

Table 68. Glycostem Therapeutics Natural Killer Cells Therapeutics Product

Table 69. Glycostem Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2019-2024) & (US$ Million)

Table 70. Glycostem Therapeutics Recent Development

Table 71. Innate Pharma Company Detail

Table 72. Innate Pharma Business Overview

Table 73. Innate Pharma Natural Killer Cells Therapeutics Product

Table 74. Innate Pharma Revenue in Natural Killer Cells Therapeutics Business (2019-2024) & (US$ Million)

Table 75. Innate Pharma Recent Development

Table 76. Nantkwest Company Detail

Table 77. Nantkwest Business Overview

Table 78. Nantkwest Natural Killer Cells Therapeutics Product

Table 79. Nantkwest Revenue in Natural Killer Cells Therapeutics Business (2019-2024) & (US$ Million)

Table 80. Nantkwest Recent Development

Table 81. Nkarta Therapeutics Company Detail

Table 82. Nkarta Therapeutics Business Overview

Table 83. Nkarta Therapeutics Natural Killer Cells Therapeutics Product

Table 84. Nkarta Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2019-2024) & (US$ Million)

Table 85. Nkarta Therapeutics Recent Development

Table 86. NKT Therapeutics Company Detail

Table 87. NKT Therapeutics Business Overview

Table 88. NKT Therapeutics Natural Killer Cells Therapeutics Product

Table 89. NKT Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2019-2024) & (US$ Million)

Table 90. NKT Therapeutics Recent Development

Table 91. Ziopharm Oncology Company Detail

Table 92. Ziopharm Oncology Business Overview

Table 93. Ziopharm Oncology Natural Killer Cells Therapeutics Product

Table 94. Ziopharm Oncology Revenue in Natural Killer Cells Therapeutics Business (2019-2024) & (US$ Million)

Table 95. Ziopharm Oncology Recent Development

Table 96. Research Programs/Design for This Report

Table 97. Key Data Information from Secondary Sources

Table 98. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Natural Killer Cells Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Natural Killer Cells Therapeutics Market Share by Type: 2023 VS 2030

Figure 3. NK Cell Therapies Features

Figure 4. NK Cell Directed Antibodies Features

Figure 5. Global Natural Killer Cells Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 6. Global Natural Killer Cells Therapeutics Market Share by Application: 2023 VS 2030

Figure 7. Cancer Case Studies

Figure 8. Gastrointestinal Diseases Case Studies

Figure 9. Immunoproliferative Disorders Case Studies

Figure 10. Others Case Studies

Figure 11. Natural Killer Cells Therapeutics Report Years Considered

Figure 12. Global Natural Killer Cells Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global Natural Killer Cells Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Natural Killer Cells Therapeutics Market Share by Region: 2023 VS 2030

Figure 15. Global Natural Killer Cells Therapeutics Market Share by Players in 2023

Figure 16. Global Top Natural Killer Cells Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Natural Killer Cells Therapeutics as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by Natural Killer Cells Therapeutics Revenue in 2023

Figure 18. North America Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America Natural Killer Cells Therapeutics Market Share by Country (2019-2030)

Figure 20. United States Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Canada Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Natural Killer Cells Therapeutics Market Share by Country (2019-2030)

Figure 24. Germany Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. France Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. U.K. Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Italy Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Russia Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Nordic Countries Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Natural Killer Cells Therapeutics Market Share by Region (2019-2030)

Figure 32. China Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Japan Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. South Korea Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Southeast Asia Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. India Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Australia Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Natural Killer Cells Therapeutics Market Share by Country (2019-2030)

Figure 40. Mexico Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Brazil Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Natural Killer Cells Therapeutics Market Share by Country (2019-2030)

Figure 44. Turkey Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Saudi Arabia Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Affimed Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2019-2024)

Figure 47. Celgene Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2019-2024)

Figure 48. Fate Therapeutics Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2019-2024)

Figure 49. Fortress Biotech Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2019-2024)

Figure 50. Glycostem Therapeutics Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2019-2024)

Figure 51. Innate Pharma Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2019-2024)

Figure 52. Nantkwest Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2019-2024)

Figure 53. Nkarta Therapeutics Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2019-2024)

Figure 54. NKT Therapeutics Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2019-2024)

Figure 55. Ziopharm Oncology Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2019-2024)

Figure 56. Bottom-up and Top-down Approaches for This Report

Figure 57. Data Triangulation

Figure 58. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions